Research Article

Global Trends on Rotavirus Vaccine’s Studies

Volume: 6 Number: 2 August 30, 2022
EN TR

Global Trends on Rotavirus Vaccine’s Studies

Abstract

Objective: The aim of the current study was to investigate global research trends and collaborations on the Rotavirus vaccines. Methods: We conducted bibliometric research in this study on the Web of Science database with the keywords related to the rotavirus vaccine. And also visualization techniques were used for mapping the collaborations. We only included the research articles and review articles. Results: We reached 5093 publications according to our search, and 52.916% were published as open access. The most preferred publication languages were English (96.682%). Most of the articles (13.627%) on the rotavirus vaccine were published in the Vaccine journal. The publications were from 164 countries globally. Most of the publications were from the United States of America (USA) (42.981%), England (9.641%), India (6.892%), Australia (6.146%), and Belgium (5.910%). The Centers For Disease Control Prevention, League of European Research Universities Leru, and World Health Organization (WHO) were the leading affiliations on rotavirus vaccine studies. The H indexes of the publications from the USA were higher (H index: 127), but the Belgian publications’ average number of citations per publication was the highest. Conclusions: The quantity of papers on the rotavirus vaccine has increased over time. The Centers for Disease Control and Prevention, the League of European Research Universities Leru, and the WHO were the most active institutions, and the USA was the most productive country. The number of publications from countries where the disease is common was below the desired level.

Keywords

Project Number

yok

References

  1. 1. World Health Organization (2013). "Rotavirus vaccines: WHO position paper—January 2013". Weekly Epidemiological Record. 88 (5): 49–64.
  2. 2. Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003; 9:565.
  3. 3. Alkan S, Dindar Demiray EK, Akça A, et al. Nozokomiyal Rotavirüs Enfeksiyonları. Black Sea Journal of Health Science. 2022; 5(1): 138-142.
  4. 4. International Vaccine Access Center. Available at: http://view-hub.org (Accessed on March 14, 2022).
  5. 5. Soares-Weiser K, Bergman H, Henschke N, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2019;3(3):CD008521. doi:10.1002/14651858.CD008521.pub4
  6. 6. Changotra H, Vij A. Rotavirus virus-like particles (RV-VLPs) vaccines: An update. Rev Med Virol. 2017; 27.
  7. 7. Bhandari N, Rongsen-Chandola T, Bavdekar A, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014; 383:2136.
  8. 8. Cunliffe NA, Bresee JS, Hart CA. Rotavirus vaccines: development, current issues and future prospects. J Infect. 2002; 45:1.

Details

Primary Language

English

Subjects

Infectious Diseases

Journal Section

Research Article

Publication Date

August 30, 2022

Submission Date

May 11, 2022

Acceptance Date

July 23, 2022

Published in Issue

Year 2022 Volume: 6 Number: 2

APA
Uyar, C., & Mızrakçı, S. (2022). Global Trends on Rotavirus Vaccine’s Studies. Journal of Biotechnology and Strategic Health Research, 6(2), 146-153. https://doi.org/10.34084/bshr.1115592
AMA
1.Uyar C, Mızrakçı S. Global Trends on Rotavirus Vaccine’s Studies. J Biotechnol and Strategic Health Res. 2022;6(2):146-153. doi:10.34084/bshr.1115592
Chicago
Uyar, Cemile, and Serpil Mızrakçı. 2022. “Global Trends on Rotavirus Vaccine’s Studies”. Journal of Biotechnology and Strategic Health Research 6 (2): 146-53. https://doi.org/10.34084/bshr.1115592.
EndNote
Uyar C, Mızrakçı S (August 1, 2022) Global Trends on Rotavirus Vaccine’s Studies. Journal of Biotechnology and Strategic Health Research 6 2 146–153.
IEEE
[1]C. Uyar and S. Mızrakçı, “Global Trends on Rotavirus Vaccine’s Studies”, J Biotechnol and Strategic Health Res, vol. 6, no. 2, pp. 146–153, Aug. 2022, doi: 10.34084/bshr.1115592.
ISNAD
Uyar, Cemile - Mızrakçı, Serpil. “Global Trends on Rotavirus Vaccine’s Studies”. Journal of Biotechnology and Strategic Health Research 6/2 (August 1, 2022): 146-153. https://doi.org/10.34084/bshr.1115592.
JAMA
1.Uyar C, Mızrakçı S. Global Trends on Rotavirus Vaccine’s Studies. J Biotechnol and Strategic Health Res. 2022;6:146–153.
MLA
Uyar, Cemile, and Serpil Mızrakçı. “Global Trends on Rotavirus Vaccine’s Studies”. Journal of Biotechnology and Strategic Health Research, vol. 6, no. 2, Aug. 2022, pp. 146-53, doi:10.34084/bshr.1115592.
Vancouver
1.Cemile Uyar, Serpil Mızrakçı. Global Trends on Rotavirus Vaccine’s Studies. J Biotechnol and Strategic Health Res. 2022 Aug. 1;6(2):146-53. doi:10.34084/bshr.1115592

Cited By

Journal of Biotechnology and Strategic Health Research